Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
8.48
-0.17 (-1.97%)
May 14, 2025, 12:46 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Treatments for Inflammatory Diseases
2.37M
Log In
Log In
Treatments for Inflammatory Diseases Growth
-0.42%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Japan
2.37M
Log In
Log In
Japan Growth
-0.42%
Log In
Log In